Trial record 1 of 1 for:    MK8931-017
Previous Study | Return to List | Next Study

An Efficacy and Safety Trial of MK-8931 in Mild to Moderate Alzheimer's Disease (P07738) (EPOCH)

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2014 by Merck Sharp & Dohme Corp.
Sponsor:
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp.
ClinicalTrials.gov Identifier:
NCT01739348
First received: November 29, 2012
Last updated: May 8, 2014
Last verified: May 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2020
  Estimated Primary Completion Date: April 2017 (Final data collection date for primary outcome measure)